​

Funding Round

Series A - Colossal Biosciences

Series A - Colossal Biosciences

Investment Firm

Overview

Colossal is a bioscience and genetic engineering company that focuses on de-extinction of past species.

Announced Date

Mar 09, 2022

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Thomas Tull

Thomas Tull

Thomas Tull is a seed firm.

At One Ventures

At One Ventures

At One Ventures is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

19

Investor Name
Participant InvestorRobert Nelsen
Participant InvestorDraper Associates
Participant InvestorBuilders VC
Participant InvestorBold Capital Partners
Participant InvestorAnimoca Brands

Round Details and Background

Colossal Biosciences raised $60000000 on 2022-03-09 in Series A

Colossal is a bioscience and genetic engineering company that focuses on de-extinction of past species.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 09, 2022
Series A - Colossal Biosciences
19-60.0M
Oct 03, 2022
Grant - Colossal Biosciences
1-undefined
Jan 31, 2023
Series B - Colossal Biosciences
14-162.6M
Nov 13, 2023
Venture Round - Colossal Biosciences
-10.5M

Recent Activity

There is no recent news or activity for this profile.